Evidence map›Paper›PMID 35389353›Full record

ArticleJMIR cancer2022

Physicians' Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle-Income Countries.

Srinivas Emani, Angela Rui, Hermano Alexandre Lima Rocha, Rubina F Rizvi, Sergio Ferreira Juaçaba, Gretchen Purcell Jackson, David W Bates

Abstract read
In one paragraph

Article in JMIR cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Srinivas Emani *Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.ORCID https://orcid.org/0000-0002-6217-5792
Angela Rui *Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.ORCID https://orcid.org/0000-0002-9635-801X
Hermano Alexandre Lima RochaDepartment of Community Health, Federal University of Cearrá, Fortaleza, CE, Brazil.ORCID https://orcid.org/0000-0001-9096-0969
Rubina F RizviIBM Watson Health, IBM, Cambridge, MA, United States.ORCID https://orcid.org/0000-0001-9432-3086
Sergio Ferreira JuaçabaInstituto do Câncer do Ceará, Fortaleza, CE, Brazil.ORCID https://orcid.org/0000-0001-7802-1803
Gretchen Purcell JacksonIntuitive Surgical, Sunnyvale, CA, United States.ORCID https://orcid.org/0000-0002-3242-8058
David W BatesDivision of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.ORCID https://orcid.org/0000-0001-6268-1540

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As technology continues to improve, health care systems have the opportunity to use a variety of innovative tools for decision-making, including artificial intelligence (AI) applications. However, there has been little research on the feasibility and efficacy of integrating AI systems into real-world clinical practice, especially from the perspectives of clinicians who use such tools. In this paper, we review physicians' perceptions of and satisfaction with an AI tool, Watson for Oncology, which is used for the treatment of cancer. Watson for Oncology has been implemented in several different settings, including Brazil, China, India, South Korea, and Mexico. By focusing on the implementation of an AI-based clinical decision support system for oncology, we aim to demonstrate how AI can be both beneficial and challenging for cancer management globally and particularly for low-middle-income countries. By doing so, we hope to highlight the need for additional research on user experience and the unique social, cultural, and political barriers to the successful implementation of AI in low-middle-income countries for cancer care.

Indexed as

artificial intelligencecancerimplementationlocal contextlow-middle–income countriesperceptionsphysiciansWatson for Oncology

Identifiers

PMID35389353
PMCPMC9030908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.